75 related articles for article (PubMed ID: 35505923)
1. In silico investigation of phytoconstituents from Cameroonian medicinal plants towards COVID-19 treatment.
Chtita S; Fouedjou RT; Belaidi S; Djoumbissie LA; Ouassaf M; Qais FA; Bakhouch M; Efendi M; Tok TT; Bouachrine M; Lakhlifi T
Struct Chem; 2022; 33(5):1799-1813. PubMed ID: 35505923
[TBL] [Abstract][Full Text] [Related]
2. Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors.
Fouedjou RT; Chtita S; Bakhouch M; Belaidi S; Ouassaf M; Djoumbissie LA; Tapondjou LA; Abul Qais F
J Biomol Struct Dyn; 2022; 40(19):8615-8629. PubMed ID: 33908318
[TBL] [Abstract][Full Text] [Related]
3. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
4. Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2.
Gupta A; Chauhan SS; Gaur AS; Parthasarathi R
Struct Chem; 2022; 33(6):2179-2193. PubMed ID: 36093277
[TBL] [Abstract][Full Text] [Related]
5. Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M
Bharadwaj KK; Sarkar T; Ghosh A; Baishya D; Rabha B; Panda MK; Nelson BR; John AB; Sheikh HI; Dash BP; Edinur HA; Pati S
Appl Biochem Biotechnol; 2021 Oct; 193(10):3371-3394. PubMed ID: 34212286
[TBL] [Abstract][Full Text] [Related]
6. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
[TBL] [Abstract][Full Text] [Related]
7. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking and ADMET studies of
Adegbola PI; Semire B; Fadahunsi OS; Adegoke AE
Virusdisease; 2021 Mar; 32(1):85-97. PubMed ID: 33869672
[TBL] [Abstract][Full Text] [Related]
9. Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study.
Nag A; Banerjee R; Chowdhury RR; Krishnapura Venkatesh C
Virusdisease; 2021 Mar; 32(1):98-107. PubMed ID: 33842673
[TBL] [Abstract][Full Text] [Related]
10. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
11.
Teli DM; Shah MB; Chhabria MT
Front Mol Biosci; 2020; 7():599079. PubMed ID: 33542917
[TBL] [Abstract][Full Text] [Related]
12. Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CL
Daoui O; Elkhattabi S; Chtita S
Struct Chem; 2022; 33(5):1667-1690. PubMed ID: 35818588
[TBL] [Abstract][Full Text] [Related]
13. Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex.
Kumar BH; Manandhar S; Mehta CH; Nayak UY; Pai KSR
Chem Zvesti; 2022; 76(2):1063-1083. PubMed ID: 34690412
[TBL] [Abstract][Full Text] [Related]
14. Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics.
Sawant S; Patil R; Khawate M; Zambre V; Shilimkar V; Jagtap S
In Silico Pharmacol; 2021; 9(1):44. PubMed ID: 34306960
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
Shah A; Patel V; Parmar B
Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
[TBL] [Abstract][Full Text] [Related]
16. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
17. The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach.
Elkaeed EB; Khalifa MM; Alsfouk BA; Alsfouk AA; El-Attar AMM; Eissa IH; Metwaly AM
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422263
[TBL] [Abstract][Full Text] [Related]
18.
Mujwar S; Harwansh RK
Struct Chem; 2022; 33(5):1517-1528. PubMed ID: 35502321
[TBL] [Abstract][Full Text] [Related]
19. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
